N Engl J Med January 2021 PMID 33332778

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.

David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, Shazia Ali, Haitao Gao, Rafia Bhore, Bret J Musser, Yuhwen Soo, Diana Rofail, Joseph Im, Christina Perry, Cynthia Pan, Romana Hosain, Adnan Mahmood, John D Davis

Mentions

390
Peak: 58 in Jul 2021
across 7 sources since Dec 2020

Extended reach

2,338,114
potential audience

Total likes

7,342

Video views

316,518

Mentions per month

Dec 2020 – Dec 2024

Where it's discussed

  • X / Twitter267 posts
  • News90 articles
  • Blogs15 articles
  • Facebook10 posts
  • Reddit4 posts
  • YouTube3 videos
  • Bluesky1 posts

AI synopsis

What people are saying

Many discussions reference the study's conclusions, such as 'the REGN-COV2 antibody cocktail reduced viral load, particularly in those without previous antibody responses.' Participants are eager to compare this treatment with others, noting comparisons with Paxlovid and Molnupiravir, highlighting the research's relevance. The tone is generally informative, with phrases like 'promising results' and 'significant implications,' helping to foster a sense of urgency and interest in the subject matter.

AgreementModerate agreement

The bulk of discussions express a moderate level of support for REGN-COV2's conclusions regarding its efficacy.

InterestHigh interest

Posters display a high level of curiosity, often referencing details from the publication and comparing it with other Covid-19 treatments.

EngagementModerate engagement

Participants are moderately engaged, discussing specific results and implications, but some posts show dismissive attitudes towards opposing views.

ImpactHigh impact

Many believe the findings have significant implications for outpatient Covid-19 treatment, suggesting they could change approaches to managing the disease.

Abstract in brief

  • REGN-COV2 is a cocktail of two neutralizing monoclonal antibodies designed to combat Covid-19 in nonhospitalized patients, with a focus on reducing viral loads and the risk of treatment-resistant mutations.
  • In a trial involving 275 patients, those receiving REGN-COV2 showed a significant reduction in viral load compared to the placebo, particularly in patients who were initially serum antibody-negative.
  • Adverse reactions were similar in both REGN-COV2 and placebo groups, indicating that the treatment was relatively safe for patients.

Top posts

Most liked on X and Bluesky
Eric Topol
@EricTopol · X

The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for people w/o native Ab response —Time of symptom onset does not correlate w/ Ab response https://t.co/itwnZp2GzZ https://t.co/JOfiJyQgI4

Dec 17, 2020 · 130 likes · 42 shares · 678,544 followers View post →
influenzer
@influenzer3 · X

→抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/K3bNhCZxdp

Jul 20, 2021 · 72 likes · 33 shares · 37,857 followers View post →
勝俣範之
@Katsumata_Nori · X

新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていません。https://t.co/lAMZeviB2U

Jul 30, 2021 · 53 likes · 20 shares · 54,709 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #VisualAbstract by @hellokidneyMD

Sep 21, 2021 · 51 likes · 9 shares · 33,516 followers View post →
influenzer
@influenzer3 · X

2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/znEhmakdeF

Jan 14, 2021 · 43 likes · 16 shares · 37,857 followers View post →
David Lee, MD
@DaveLeeERMD · X

Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated with mAbs, viral load also dropped significantly by 7 days in both study arms. Viral load appears to be highest at symptom onset. https://t.co/vIKJvz7XjA

Aug 20, 2021 · 27 likes · 7 shares · 8,828 followers View post →

All mentions

grownwildinaz
@grownwildinaz · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | New England Journal of Medicine https://t.co/y1MDxiYNBf

Dec 10, 2024 · 1,656 followers View post →
Landofoz2008
@landofoz2008 · X

@ShteinMichael https://t.co/wPRXhl4OEs https://t.co/lX9KAEZsyH

May 4, 2024 · 1,128 followers View post →
UsainDoc
@UsainDoc · X

RT @sudokuvariante: Voici quelques points de comparaison avec le paxlovid, le molnupiravir, et certains anticorps monoclonaux. Données des…

Jan 19, 2023 · 3 shares · 1,220 followers View post →
FANTONI
@FANTONI1 · X

RT @sudokuvariante: Voici quelques points de comparaison avec le paxlovid, le molnupiravir, et certains anticorps monoclonaux. Données des…

Jan 18, 2023 · 3 shares · 502 followers View post →
justice for all
@jcd92410 · X

RT @sudokuvariante: Voici quelques points de comparaison avec le paxlovid, le molnupiravir, et certains anticorps monoclonaux. Données des…

Jan 18, 2023 · 3 shares · 898 followers View post →
Fred Stalder
@sudokuvariante · X

Voici quelques points de comparaison avec le paxlovid, le molnupiravir, et certains anticorps monoclonaux. Données des études: https://t.co/Zt9XqvB2ws https://t.co/O4YxHPARaj https://t.co/7gwYGNm8Xn https://t.co/amAJWK2dkJ 6/n https://t.co/YlACj3PYQV

Jan 18, 2023 · 12 likes · 3 shares · 4,673 followers View post →
Fred Stalder
@sudokuvariante · X

Delete my tweet by mistake... Ivermectin (Chaccour) Paxlovid (Hammond) Regeneron (Weinreich, Table S2) https://t.co/amAJWK2dkJ https://t.co/QRrJS6sXER

Jan 16, 2023 · 4,673 followers View post →
Derek
@Derek67713647 · X

Got COVID? Watch this for outpatient treatment options available in 2022 https://t.co/dmmq5MyhLn via @YouTube

Dec 27, 2022 · 132 followers View post →
G.S
@jubelie · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/Q3o8SDcMOS

Mar 1, 2022 · 60 followers View post →
TechHelp
@TechHelp · X

@Minkiemom17 @chuha @Tangento In this interim analysis, the REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load https://t.co/Hibb7oBinl

Jan 27, 2022 · 627 followers View post →
Some Must Go To Prison
@AlienistG · X

@galswguitars202 @NikkiFried Wrong again. https://t.co/4XkKSKr6Ph

Jan 25, 2022 · 425 followers View post →
Gary J
@GarySIBeach · X

Got COVID? Watch this for outpatient treatment options available in 2022 https://t.co/JwnWbZ6IxJ via @YouTube

Jan 25, 2022 · 125 followers View post →
karen
@karenleonhardt3 · X

Got COVID? Watch this for outpatient treatment options available in 2022 https://t.co/cU1sgYQtBy via @YouTube

Jan 18, 2022 · 842 followers View post →
Syd Winarchist
@syd_winarchist · X

@Buscusriot @PeterMcCormack @Timcast https://t.co/wJ4nTGcgiQ https://t.co/W7WMy3H2ij https://t.co/sPXcdi7Jsg https://t.co/MkDeW0gsFy. Study (but don't trust) the science bro

Jan 18, 2022 · 2 likes · 452 followers View post →
memes
@ail7137107ailll · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/rvhgsuFpj6

Jan 18, 2022 · 574 followers View post →
Brent Joseph
@Dallas004 · X

Monoclonal Antibodies - What you NEED to know! https://t.co/SPhXLShm9b via @YouTube

Jan 9, 2022 · 1,110 followers View post →
ishidomaru
@ishidomaru · X

Got COVID? Watch this for outpatient treatment options available in 2022 https://t.co/niOLDtd7Fk @YouTubeより

Jan 8, 2022 · 359 followers View post →
RECombatant
@windgineering · X

@KenWarnock @DrLeanaWen The source is the source is 5:20 of this video, from Dr Christy Risinger: https://t.co/eUdoDNLHTP She is also for vaccines. @chrismartenson, a PhD epidemiologist, highlighted ivermectin’s effectiveness well before the first “COVID vaccines”. The problem is willfull ignorance.

Jan 8, 2022 · 3 likes · 1,212 followers View post →
lourdes tuers
@ltuers550 · X

https://t.co/smGbBkd1Ly

Dec 26, 2021 · 213 followers View post →
la la la
@meilt16801 · X

Monoclonal Antibodies - What you NEED to know! https://t.co/0IABxBQX0j via @YouTube

Dec 26, 2021 · 93 followers View post →
MG
@immunotoxPhD · X

@roseyx8 @KGJ26 @TimMalia Monoclonal: https://t.co/uHXR3eKCpZ Vaccination: https://t.co/mo3t0zSBOM https://t.co/du1aDuLYUE https://t.co/Ndt61lSyKm

Nov 27, 2021 · 718 followers View post →
Laureen Cummings
@LaureenCummings · X

Also available to PREVENT COVID IF EXPOSED! Monoclonal Antibodies - What you NEED to know! https://t.co/U98TwmSFv2 via @YouTube

Nov 21, 2021 · 1 like · 1,383 followers View post →
Amol D. Kothalkar MBBS, MD, DNB(Cardiology), FIC
@hypomaniac07 · X

@ABsteward @DrToddLee @InfectiousDz @TogetherTrial https://t.co/m5CyCWuk0P

Nov 1, 2021 · 300 followers View post →
Прелесть галлюцинаций
@lazyneocortex · X

@Tatademurcia предполагаю, что они, для профилактики, вот это употребляют: https://t.co/A0kq1cRbG2

Oct 31, 2021 · 1,478 followers View post →
valeria.rolla
@rollavaleria · X

@leandrotessler @binerighetti https://t.co/1v01FMv723

Oct 31, 2021 · 236 followers View post →
valeria.rolla
@rollavaleria · X

@leandrotessler @binerighetti https://t.co/1v01FMv723

Oct 31, 2021 · 236 followers View post →
valeria.rolla
@rollavaleria · X

@leandrotessler @binerighetti Esse é o trial inicial https://t.co/1v01FMv723

Oct 31, 2021 · 236 followers View post →
Ester Gerová
@EsterGerova · X

@PetrLudwig Pište o novém způsobu léčby coronaviru, o kterém se málo píše: https://t.co/c2oLIFJpNG V Česku zatím v dávce 12 000, neregistrovaný lék...

Oct 29, 2021 · 32 followers View post →
ईश
@ishan6 · X

https://t.co/wWdWHK0WJi

Oct 28, 2021 · 428 followers View post →
浅利 幸子
@asarsach31 · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 - https://t.co/oj1z87YYw2 https://t.co/i58swHBHgC

Oct 25, 2021 · 1 followers View post →
Smile Chill
@Smile_Chilll · X

RT @lazyneocortex: уже писала, что в США больше года, в лечении ковида, используют моноклональные антитела. помните как Трамп болел 1 день…

Oct 23, 2021 · 1 share · 794 followers View post →
Jeff Segor
@JSegor · X

RT @MDaware: @JSegor @MonicaGandhi9 we do know that. ARR from mAbs is on the order of 3-9%, vs something like 90% for vaccines and, again,…

Oct 19, 2021 · 1 share · 755 followers View post →
Seth Trueger
@MDaware · X

@JSegor @MonicaGandhi9 we do know that. ARR from mAbs is on the order of 3-9%, vs something like 90% for vaccines and, again, mAbs don't protect those around you https://t.co/daQ16wi9AX https://t.co/W5mpmKm8FL https://t.co/2HKGcz3pKa

Oct 19, 2021 · 2 likes · 1 share · 57,685 followers View post →
Прелесть галлюцинаций
@lazyneocortex · X

уже писала, что в США больше года, в лечении ковида, используют моноклональные антитела. помните как Трамп болел 1 день? вот! сейчас ученые утверждают, что коктейль REGEN-COV можно использовать для профилактики. подробней об исследовании https://t.co/A0kq1cRbG2

Oct 18, 2021 · 2 likes · 1 share · 1,478 followers View post →
Michael A. Lewis (bball name to the kids, OG)
@MichaelALewis10 · X

From this: https://t.co/NoLA5xVWbY it looks like the research was done before vaxx were in place so I assume the findings are from a nonvaxxed sample. Again, wondering if this also holds for a vaxxed sample.

Oct 13, 2021 · 1,015 followers View post →
Ana Carolina Peçanha
@AnaCarolPecanha · X

Regeneron desenvolveu o coquetel de Ac neutralizantes (casirivimab e imdevimab) contra epítopos da proteína S-spike, retendo capacidade de ação in vitro contra todas as variantes de preocupação até o momento. O estudo de fase II foi publicado em dez/2020: https://t.co/8WHtZWIckj

Oct 6, 2021 · 10 likes · 5,326 followers View post →
Laurie Burnell
@burnelll · X

@KTVB https://t.co/sxCEOipu5I

Sep 28, 2021 · 1,075 followers View post →
Harry Thomas
@DrHarryThomas · X

@CMichaelGibson Do they even work in vaccinated patients? L: nonhospitalized patients https://t.co/RLvfjsjFUp R: hospitalized patients https://t.co/0er7HWsv5G https://t.co/1HV78xG8WD

Sep 22, 2021 · 2 likes · 33,253 followers View post →
Harry Thomas
@DrHarryThomas · X

@DrSuperSalty That may make some sense https://t.co/RLvfjsjFUp https://t.co/Unkqaokqfl

Sep 22, 2021 · 1 like · 33,253 followers View post →
Clark Ramos
@ClarkSRamos · X

Monoclonal Antibodies - What you NEED to know! https://t.co/EIy4Z69Wyd via @YouTube

Sep 22, 2021 · 23 followers View post →
Tzippy Diskind صِپورة #JusticeForMalkiRoth
@zpyarom · X

RT @zpyarom: מחקרים על הטיפול: https://t.co/RoCgwNePmu וגם https://t.co/Mwhi2EpmAW למי שרוצה לחפש מידע נוסף באנגלית, הביטוי הוא monoclo…

Sep 22, 2021 · 1 share · 3,513 followers View post →
Tzippy Diskind صِپورة #JusticeForMalkiRoth
@zpyarom · X

מחקרים על הטיפול: https://t.co/RoCgwNePmu וגם https://t.co/Mwhi2EpmAW למי שרוצה לחפש מידע נוסף באנגלית, הביטוי הוא monoclonal antibodies, או בקיצור MAbs.

Sep 22, 2021 · 1 share · 3,513 followers View post →
LisFalafel
@Lisflipphi · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 22, 2021 · 9 shares · 101 followers View post →
najiba world
@WafaaArache · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 22, 2021 · 9 shares · 753 followers View post →
Mana
@manasigh · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 22, 2021 · 9 shares · 330 followers View post →
Letaief
@hmidato · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 22, 2021 · 9 shares · 369 followers View post →
Allin
@alinspring · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 22, 2021 · 9 shares · 573 followers View post →
ReVolBER
@RevolberMex · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 21, 2021 · 9 shares · 349 followers View post →
Carlo Trinidad
@hellokidneyMD · X

RT @edgarvlermamd: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #Visu…

Sep 21, 2021 · 9 shares · 22,339 followers View post →
Edgar V. Lerma
@edgarvlermamd · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 ca. 2021 from @NEJM #Nephpearls #NephJC #VisualAbstract by @hellokidneyMD

Sep 21, 2021 · 51 likes · 9 shares · 33,516 followers View post →
Brad M.D.
@BradMD · X

Sub Q Regeneron https://t.co/VCz2UFINaA

Sep 21, 2021 · 23,393 followers View post →
Poliorcetes
@PoliorcetesMD · X

https://t.co/wuqqCNZWd8

Sep 20, 2021 · 42 followers View post →
Israel Cancel
@israel_cancel · X

Monoclonal Antibodies - What you NEED to know! https://t.co/1Q4T56gOoI via @YouTube

Sep 20, 2021 · 309 followers View post →
Dan Comfort
@Dan_Comfort · X

https://t.co/7sWE2CTeNR

Sep 19, 2021 · 200 followers View post →
Jack Diodato
@justjack613 · X

Monoclonal Antibodies - What you NEED to know! https://t.co/ccVOuVZ6RR via @YouTube

Sep 18, 2021 · 171 followers View post →
adeyu/チョコミン党
@th_adieu · X

We prospectively pursued a “cocktail” approach because of previous experience with the emergence of treatment-resistant mutant virus when a single antibody, suptavumab, was used to target respiratory syncytial virus. https://t.co/LXqX9VcmkT

Sep 18, 2021 · 1 like · 1 share · 1,887 followers View post →
imacynic
@imacynictoo_ · X

Monoclonal Antibodies - What you NEED to know! https://t.co/yTHi7fsJef via @YouTube

Sep 16, 2021 · 1,951 followers View post →
BJ Bolander
@bj_bolander · X

Monoclonal Antibodies - What you NEED to know! https://t.co/4NzN4i2OgH via @YouTube

Sep 15, 2021 · 1 like · 1,378 followers View post →
Digital Energy 23
@DigitalEnergy23 · X

Monoclonal Antibodies - What you NEED to know! https://t.co/LrXrnV9S9G via @YouTube

Sep 15, 2021 · 198 followers View post →
Fernando Suárez Obando
@FerSuarezMD · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/c26YTzXfwz

Sep 15, 2021 · 4,868 followers View post →
kristiwarsha
@kristiwarsha · X

Monoclonal Antibodies - What you NEED to know! https://t.co/blGuJ7P4bw via @YouTube

Sep 11, 2021 · 89 followers View post →
Chris Street
@ChrisGStreet · X

#monoclonal #antibody @Regeneron #Casirivimab/#imdevimab, @EliLillyCo #Bamlanivimab/#etesevimab, @GSK #Sotrovimab #Covid_19 reduce: eg 71% hospitalisations, 70% deaths, 4 days recovery time. For #post-#exposure #prophylaxis & #early #treatment. Vaxx also. https://t.co/0zsFMXwcGL

Sep 11, 2021 · 601 followers View post →
Abdulaziz N. Algain
@The_Lazy_Nerd · X

Monoclonal Antibodies - What you NEED to know! https://t.co/HUpf9g886C via @YouTube

Sep 10, 2021 · 2,112 followers View post →
Dr. Bob
@RearseatRobert · X

@AbeV4U @Patchemup1 @EcmoNinja Nah look at the trials themselves. They get the percentage from a difference in 3 vs. 6 “medically attended visits” that they don’t describe as Covid-related or not between treatment and placebo groups. Judge for yourself: https://t.co/RcSEfUMFHL

Sep 8, 2021 · 404 followers View post →
koureiigaku
@koureiigaku · X

3.SARS-CoV-2変異株の一部はワクチンや回復期血清、モノクローナル抗体に対する感受性低下を示して*おり、すでにモノクローナル抗体の併用*などが行われています。 https://t.co/suKBwWhq9S https://t.co/2K4w0MeiWQ https://t.co/d7xfX17WIF https://t.co/D1qDBYcQos https://t.co/NOx6vLoTle

Sep 7, 2021 · 850 followers View post →
koureiigaku
@koureiigaku · X

加えてSARS-CoV-2感染者の内因性免疫応答の多くは感染に対して有効に働く*という報告もあり、職員においてbamlanivimabが偽薬を上回る有効性を示されなかった本試験の結果と一致しています。 https://t.co/NOx6vLoTle

Sep 6, 2021 · 850 followers View post →
鯵ゼミ_Journal Club
@AJSR_since2005 · X

#057 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 N Engl J Med 2021;384:238-51.

Sep 4, 2021 · 6 followers View post →
Dogs&Viruses
@Craigster771 · X

@NPR He took Regeneron’s antibody cocktail. Hardly unproven. https://t.co/eT3WD1grKC

Sep 1, 2021 · 1 like · 586 followers View post →
Angie policelli
@Angiepolicelli2 · X

RT @DrHirschfield: An outpatient study measuring viral load reduction, a subset showed statistical sig reduction of viral load. Co-endpoint…

Aug 31, 2021 · 2 shares · 2,940 followers View post →
Howard Hamilton
@BubbaCanyon · X

@Ron_Nirenberg @UnivHealthSA @BaptistHealthSA @SouthTexasMed @bcms_org when will healthcare providers proactively offer monoclonal antibodies to #COVID patients early in their illness ? Numerous studies indicate these drugs can reduce hospitalizations https://t.co/YOdkLn1Bxb

Aug 30, 2021 · 16 followers View post →
Jeffrey A. Hirschfield, MD
@DrHirschfield · X

An outpatient study measuring viral load reduction, a subset showed statistical sig reduction of viral load. Co-endpoint is proportion of at least one medically attended visit. This study did not determine clinical benefit. https://t.co/cc7roMx20u https://t.co/eilxawXM7v

Aug 30, 2021 · 2 likes · 2 shares · 11,961 followers View post →
i̵a̶n̸.
@IanMDesigns · X

@Skidancer2 @RichSpence10 @gartmartin9 @GovRonDeSantis Maybe follow the science? https://t.co/c6Co2geMQk

Aug 29, 2021 · 1 like · 549 followers View post →
i̵a̶n̸.
@IanMDesigns · X

@gartmartin9 @GovRonDeSantis I thought you were supposed to follow the science? ☕️

Aug 29, 2021 · 549 followers View post →
氷
@koorinono · X

RT @hichachu: 文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;…

Aug 28, 2021 · 5 shares · 589 followers View post →
はちべえ
@8beichan · X

RT @hichachu: 文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;…

Aug 28, 2021 · 5 shares · 2,468 followers View post →
kemofure
@kemohure · X

RT @hichachu: 文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;…

Aug 28, 2021 · 5 shares · 13,377 followers View post →
kayochan
@deen_kayo · X

RT @hichachu: 文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;…

Aug 27, 2021 · 5 shares · 1,163 followers View post →
_∭ arctan
@_JJ_7 · X

RT @hichachu: 文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;…

Aug 27, 2021 · 5 shares · 1,208 followers View post →
ニューロドクター乱夢
@hichachu · X

文献10 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. Weinreich DM et al N Engl J Med. 2021 Jan 21;384:238-251 https://t.co/UTVlFLKle0 抗体カクテルはウイルス量を減らし免疫応答がまだ開始されていない患者やベースラインでウイルス量が多い患者に大きな効果

Aug 27, 2021 · 8 likes · 5 shares · 4,260 followers View post →
Speaking My Mind
@sherryande · X

https://t.co/q5yvPifVqU

Aug 26, 2021 · 1 like · 4,551 followers View post →
どこかの人
@mima09180402 · X

RT @carpe_diem0820: COVID-19患者のうち、免疫反応がまだ得られていない患者、あるいはウイルス負荷が高い患者では、Regeneron社のモノクローナル抗体カシリビマブとイムデビマブによる治療がウイルス量低減に効果 REGN-COV2, a Neutra…

Aug 24, 2021 · 4 shares · 1,587 followers View post →
Alice @PennysMom
@Penny20035 · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 21, 2021 · 7 shares · 1,111 followers View post →
Christopher Hart
@Chrishartradio · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 21, 2021 · 7 shares · 1,780 followers View post →
Alexvc
@XanderVCosta · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 21, 2021 · 7 shares · 77 followers View post →
emu
@wordsinusername · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 21, 2021 · 7 shares · 512 followers View post →
Jon Bon Jovial
@BrontoBurgerz · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 21, 2021 · 7 shares · 564 followers View post →
\dot{u}=\alpha\nabla^{2}u
@UNabla · X

@MrSirUgly But it appears to be a little like Tamiflu: you probably need to get it into you soon after infection ... "patients whose immune response had not yet been initiated" https://t.co/UZLJoNOOsb

Aug 21, 2021 · 1,844 followers View post →
Dogs&Viruses
@Craigster771 · X

@tiakiki246 @GovRonDeSantis Really? https://t.co/eT3WD1grKC

Aug 20, 2021 · 586 followers View post →
Lorenza Cauzzi
@CauzziLorenza · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 20, 2021 · 7 shares · 278 followers View post →
Tweeter
@BaDaPa · X

RT @DaveLeeERMD: Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated w…

Aug 20, 2021 · 7 shares · 87 followers View post →
David Lee, MD
@DaveLeeERMD · X

Here’s what the outpatient studies of mAbs for COVID-19 showed. While viral load decreased faster among patients treated with mAbs, viral load also dropped significantly by 7 days in both study arms. Viral load appears to be highest at symptom onset. https://t.co/vIKJvz7XjA

Aug 20, 2021 · 27 likes · 7 shares · 8,828 followers View post →
Yves
@aviyasinov · X

@GrimBeholder על תשלובת משובטת של נוגדנים במתן פלסמה הם לא שמעו או שמשרד המוות לא יידעם . הצלת חיים לא מעניינם. https://t.co/txP7hp9PMr

Aug 20, 2021 · 611 followers View post →
\dot{u}=\alpha\nabla^{2}u
@UNabla · X

@josiegirl62 @ProfPCDoherty Trump got 8 grams of REGN-COV2 but that'd probably cost us about US$6,500 right now ... and a bit like Tamiflu it seems that REGN-COV2 works best only early in the infection: https://t.co/OGHU8YXf0H.

Aug 20, 2021 · 1,844 followers View post →
4画面
@4gamen_tw · X

抗体カクテルがよくわかっていなかったのでちょっと調べた。ドラッグデザインとしては耐性株の出現抑制がポイントなのね。分かりやすかった。 https://t.co/qGCffYuDBX https://t.co/pA4B93AVgL

Aug 19, 2021 · 1 share · 437 followers View post →
AI Bot (מודע לעצמו)
@SababaUSA · X

@reserved_word @ImNotOwned Regeneron's clinical trial is in only 275 subjects lol Pfizer's EUA was supported by a study involving 43,548 subjects https://t.co/GsyqbVThRK https://t.co/YF2T6ClgUQ

Aug 19, 2021 · 2 likes · 641 followers View post →
Mª Dolores Díaz
@mdialop1 · X

RT @jrarribas: Great discussion @DrBike7. If all is "association" why in the AR0-CORONA RCT https://t.co/NRq4xjHPYI there is a significant…

Aug 18, 2021 · 1 share · 114 followers View post →
Harry Thomas
@DrHarryThomas · X

"Patients who were positive for any one of these antibodies [IgA anti-S1 domain of spike protein, IgG anti-S1 domain of spike protein, and IgG anti-nucleocapsid protein] were designated as serum antibody–positive" https://t.co/RLvfjs252R https://t.co/Z7Co2w1ut2

Aug 18, 2021 · 1 like · 33,253 followers View post →
Jose R Arribas
@jrarribas · X

Great discussion @DrBike7. If all is "association" why in the AR0-CORONA RCT https://t.co/NRq4xjHPYI there is a significant difference in favor of TDF for viral clearance of 0.8 logs @ day 7?. This is similar to what mAbs do in outpatients: 10.1056/NEJMoa2035002 (−0.56 logs) https://t.co/Ugw6n0CJyf

Aug 18, 2021 · 8 likes · 1 share · 5,589 followers View post →
Circulation 日本版
@Circulation_nih · X

RT @sgoto4: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/zdS9Ur40LI 抗体カクテルってこんなかんだね。

Aug 18, 2021 · 2 shares · 345 followers View post →
ईश
@ishan6 · X

@minnesorta @ShohamTxID @TheRickWilson https://t.co/wWdWHK0WJi https://t.co/FBpNCMtnpk

Aug 17, 2021 · 1 like · 428 followers View post →
ईश
@ishan6 · X

https://t.co/wWdWHK0WJi https://t.co/hev7XgiJ8E

Aug 17, 2021 · 428 followers View post →
Shinya Goto
@sgoto4 · X

RT @sgoto4: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/zdS9Ur40LI 抗体カクテルってこんなかんだね。

Aug 17, 2021 · 2 shares · 323 followers View post →
Shinya Goto
@sgoto4 · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/zdS9Ur40LI 抗体カクテルってこんなかんだね。

Aug 17, 2021 · 2 likes · 2 shares · 323 followers View post →
Valera
@vtownboogie · X

@carterdotmusic Ok https://t.co/rvuhDv3qBC

Aug 14, 2021 · 182 followers View post →
Thomas Davis
@TomDavisMD · X

Tell me @kerpen how these studies support the use of the mAb cocktail? Point to the confidence interval for a clinically meaningful endpoint that seals the deal. https://t.co/FWIZ1rCIzV https://t.co/tF2cTvuznY

Aug 14, 2021 · 434 followers View post →
Dogs&Viruses
@Craigster771 · X

@DirkWeezil @Moreskyplease @GovRonDeSantis Outpatient setting is also allowed https://t.co/eT3WD1grKC

Aug 13, 2021 · 586 followers View post →
AJ the Husky
@AJ_Philly · X

@bluewave_elaine @GovRonDeSantis Who says the vaccines aren’t? The data for Regeneron’s antibodies are published. Free to read. https://t.co/EXIOVUx9k1

Aug 13, 2021 · 1 like · 436 followers View post →
AJ the Husky
@AJ_Philly · X

@NerdPyle @GovRonDeSantis The studies are published whether it works or not. Free to read. Stop spreading misinformation. https://t.co/EXIOVUx9k1

Aug 13, 2021 · 3 likes · 436 followers View post →
AJ the Husky
@AJ_Philly · X

@OttoTopci @GovRonDeSantis 1. No. Read the study https://t.co/EXIOVUx9k1 2. So? 3. Not true at all. No antibodies are made using fetal tissue of any kind. Stop spreading misinformation.

Aug 13, 2021 · 1 like · 436 followers View post →
Todd McCarty
@TMcCarty2010 · X

@Bondad30360 @DrEllenEaton The mAbs are likely the best outpatient treatment, but they've not yet been shown to decrease mortality. https://t.co/zNo8XOQmU9

Aug 13, 2021 · 2,743 followers View post →
Dogs&Viruses
@Craigster771 · X

@NerdPyle @RandPaul The efficacy: https://t.co/eT3WD1grKC The cost: https://t.co/z9f02sU08P Stop lying. https://t.co/cx61VHGu3Q

Aug 13, 2021 · 586 followers View post →
Dogs&Viruses
@Craigster771 · X

@GeneralBitch @NerdPyle @RandPaul Before CoVid infection? Really? https://t.co/eT3WD1grKC

Aug 13, 2021 · 586 followers View post →
Swirvithan L. Gooding Splatt
@l_splatt · X

@CarolForden @thehowie @GovRonDeSantis Ok let's take a dive into the actual data from the studies. Here's the first two that come up when you search regeneron studies. Both support it's efficacy with similar side effects to placebo. This is what the actual data says. https://t.co/fbxYhOf8Z9 https://t.co/i0ltQp8wj0

Aug 12, 2021 · 1 like · 67 followers View post →
Swirvithan L. Gooding Splatt
@l_splatt · X

@CathyNotToday @CarolForden @thehowie @GovRonDeSantis Upon actual investigation, the first two studies I found concluded Regeneron to reduce viral load and have the same side effects as the placebo. Here's one from the New England Journal of Medicine just so you don't think I'm kidding. https://t.co/fbxYhOf8Z9

Aug 12, 2021 · 1 like · 67 followers View post →
Vanna J. Hoodlander
@vjhoodlander · X

@elise_oisen @Missy04924393 @mmpadellan You're arguing with a scientist, just saying. They have done it in both. Their EUA is for what was mentioned above. https://t.co/LHEilyQBs2

Aug 12, 2021 · 429 followers View post →
Vanna J. Hoodlander
@vjhoodlander · X

@notRaptorGuy @mmpadellan https://t.co/KJ12kXyAAY https://t.co/87GkIXZMkg https://t.co/Cd8wFgzp62 https://t.co/jutkIKXTy4 https://t.co/LHEilyQBs2 https://t.co/PEoIgUdlK2

Aug 12, 2021 · 429 followers View post →
Sha
@quip1 · X

@WalterS50823302 @Dafkagirl @WUTangKids @OneFreshPillow Like the New England Journal of Medicine is a cult? https://t.co/qqSMKKdmOb

Aug 12, 2021 · 1,150 followers View post →
Sri padmanabhan
@psrivats_mdphd · X

@upshaw_stacy Atleast 60 days or longer? monoclonals they tend to stick around. doi:10.1056/NEJMoa2035002 Even by day 30 still has significant serum levels. So longer you wait the better for spike mrna based vaccines to elicit a immune response. Will be a booster in your situation anyways.

Aug 12, 2021 · 5 likes · 256 followers View post →
David
@thinkingabt · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/6XRd4fj6Kl

Aug 12, 2021 · 1,917 followers View post →
Rafael G. B. Neves
@rgbneves · X

@Fla_Pol @GovRonDeSantis @AGGancarski https://t.co/molyB9zt8y

Aug 12, 2021 · 571 followers View post →
Rafael G. B. Neves
@rgbneves · X

@SamAtallahMD @JoeBiden @GovRonDeSantis @AnnaForFlorida @meganranney @cnnbrk @jeremyfaust @AtulGroverMD Are y’all using this? https://t.co/molyB9zt8y

Aug 12, 2021 · 571 followers View post →
Rafael G. B. Neves
@rgbneves · X

@orlandosentinel Are y’all offering this (or not yet), @orlandohealth and @AdventHealth? https://t.co/molyB9zt8y

Aug 12, 2021 · 571 followers View post →
Brock Juffs, MD
@MCCEE_Prep · X

I like how Regeneron is trying to sell that their antibody cocktail decreases death among those already infected when their article says the opposite (read the discussion) https://t.co/R92EfdGTLV #medicine #healthcare #residency #USMLE #medschool #doctor #MCCQE1 #COVID19

Aug 9, 2021 · 686 followers View post →
whysitstonky
@whysitstonky · X

@RWMaloneMD what happens if you’re given REGN-COV2 if you’ve had the pfizer vaccine?? https://t.co/RZdrW1vCnU can anyone provide feedback?

Aug 8, 2021 · 79 followers View post →
さっぽろ
@kVpoIvzZoStbXAQ · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Aug 4, 2021 · 20 shares · 395 followers View post →
ぷやにん
@EiMc3Z · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 1,015 followers View post →
medicalnews
@medsci_news · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 43 followers View post →
さくら
@MNgepe · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 507 followers View post →
koji hasegawa
@myfavoritescene · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 5,215 followers View post →
ななこ☆
@nanakoame2 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 244 followers View post →
Cerveza bibere
@YKShake0 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 2,058 followers View post →
peko
@peko409 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 6,608 followers View post →
みーちゃん
@hirokun15 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 994 followers View post →
とまはぼちぼち
@fusasippona1 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 2,246 followers View post →
cherry_blossom0423
@cherry_dogwood · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 140 followers View post →
ももこ
@momomo47 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 31, 2021 · 20 shares · 138 followers View post →
るすばんネコ
@NLPumaikoto_miu · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 54 followers View post →
kero3
@k_kero3 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 440 followers View post →
hidew
@hidew27 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 1,258 followers View post →
rindou
@rindou73181639 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 154 followers View post →
さとし
@tUuZfvSqK0jKTLd · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 103 followers View post →
angiography
@Nao76301949 · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 370 followers View post →
北斗柄@野巫の六壬者
@hokutohei · X

RT @Katsumata_Nori: 新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていま…

Jul 30, 2021 · 20 shares · 1,178 followers View post →
勝俣範之
@Katsumata_Nori · X

新型コロナに対するカクテル療法の最初の論文はこちらです。New England Journal of Medicineという世界最高峰の医学誌に載っています。医学界の金メダルです。残念ながら日本はまだ新型コロナ研究では金メダルを取っていません。https://t.co/lAMZeviB2U

Jul 30, 2021 · 53 likes · 20 shares · 54,709 followers View post →
kickxxx
@kickxxx2 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 28, 2021 · 33 shares · 41 followers View post →
NULLもどき
@mdk_dai · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 28, 2021 · 33 shares · 1,774 followers View post →
pippi
@thinkthink_3 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 27, 2021 · 33 shares · 155 followers View post →
Kazume Cat-maniac
@kazume_n · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 27, 2021 · 33 shares · 515 followers View post →
松城
@matsushiro5517 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 27, 2021 · 33 shares · 1,973 followers View post →
Tomohiko EDURA
@Tomo6216jp · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 21, 2021 · 33 shares · 1,187 followers View post →
わか❄️(「゚Д゚)「ガウガウ
@wakachuki · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 21, 2021 · 33 shares · 418 followers View post →
kurohime
@Tomigahara2013 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 696 followers View post →
FMK03
@FMK03 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,024 followers View post →
内田
@uchida_kawasaki · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,935 followers View post →
C調言葉に医療人
@SAS11taro · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 192 followers View post →
しとらす@京都
@citrus_kyoto · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,356 followers View post →
kemofure
@kemohure · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 13,377 followers View post →
Yasushi Aihara
@mundum_ipsum · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 643 followers View post →
ピョートル4世@
@Pyotr1840 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,491 followers View post →
さもありなん:TLほぼ追えてないぽんこつモードなう
@ikotto · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 351 followers View post →
yumi @gj
@ygjumi · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 12,718 followers View post →
kero3
@k_kero3 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 440 followers View post →
浅葱鼠
@motoki0 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 2,982 followers View post →
Tabatha
@araran100 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 17,562 followers View post →
よりみち(憲法97条消すな!)
@Ernie33Ns · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 829 followers View post →
hannna
@hannahumming · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 2,684 followers View post →
特別期間
@periodoespecial · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 185 followers View post →
J.un
@j2290un · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 88 followers View post →
Hisayo
@DQE0522738 · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 398 followers View post →
Akinori Hamada
@wasurenakusa · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 3,474 followers View post →
たいしょー。“wanna get higher and further”
@fearless_TAISHO · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,358 followers View post →
Taku_F / Moderna
@TakumiFukagawa · X

RT @influenzer3: →抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, i…

Jul 20, 2021 · 33 shares · 1,869 followers View post →
influenzer
@influenzer3 · X

→抗体カクテル製剤の抗ウイルス効果は確実です。 今後の位置づけとしては、入院ハイリスク患者への早期投与になるのかと思います。 RDVにとってかわる?? REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/K3bNhCZxdp

Jul 20, 2021 · 72 likes · 33 shares · 37,857 followers View post →
お薬山さん
@megoodreams · X

RT @tyabu7973: モノクローナル抗体製剤(イムデビマブ/カシリビマブ)が話題だけど、Pubmedで調べてもRCTは以下のNEJM1件のみ。 ウイルス量をアウトカムにしたRCT(n=275)で、外来患者のウイルス量が減ったよというもの しかもそれを入院で使う? h…

Jul 20, 2021 · 3 shares · 109 followers View post →
にゃあ
@kirikami · X

RT @shams_z: Some important papers on Ab Cocktails. 1. https://t.co/acPVCl3MZw 2. https://t.co/NfAXTia2lJ 3. https://t.co/BDdSskdAZF 4. ht…

Jul 19, 2021 · 3 shares · 1,867 followers View post →
にゃあ
@kirikami · X

RT @epidatum: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 REGN-COV2 antibody cocktail reduced viral load, w…

Jul 19, 2021 · 1 share · 1,867 followers View post →
にゃあ
@kirikami · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jul 19, 2021 · 16 shares · 1,867 followers View post →
にゃあ
@kirikami · X

RT @Vannyamoto: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 - PubMed 中外製薬の中和抗体を検証した臨床試験 https://t.co/Ci4xOEw…

Jul 19, 2021 · 2 shares · 1,867 followers View post →
にゃあ
@kirikami · X

RT @tyabu7973: モノクローナル抗体製剤(イムデビマブ/カシリビマブ)が話題だけど、Pubmedで調べてもRCTは以下のNEJM1件のみ。 ウイルス量をアウトカムにしたRCT(n=275)で、外来患者のウイルス量が減ったよというもの しかもそれを入院で使う? h…

Jul 19, 2021 · 3 shares · 1,867 followers View post →
中村利仁
@rijin_nakamura · X

RT @tyabu7973: モノクローナル抗体製剤(イムデビマブ/カシリビマブ)が話題だけど、Pubmedで調べてもRCTは以下のNEJM1件のみ。 ウイルス量をアウトカムにしたRCT(n=275)で、外来患者のウイルス量が減ったよというもの しかもそれを入院で使う? h…

Jul 19, 2021 · 3 shares · 7,944 followers View post →
矢吹 拓 Taku Yabuki
@tyabu7973 · X

モノクローナル抗体製剤(イムデビマブ/カシリビマブ)が話題だけど、Pubmedで調べてもRCTは以下のNEJM1件のみ。 ウイルス量をアウトカムにしたRCT(n=275)で、外来患者のウイルス量が減ったよというもの しかもそれを入院で使う? https://t.co/EFFQ0p5HOY

Jul 19, 2021 · 21 likes · 3 shares · 3,774 followers View post →
ユウナ
@ring1124303 · X

RT @Vannyamoto: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 - PubMed 中外製薬の中和抗体を検証した臨床試験 https://t.co/Ci4xOEw…

Jul 12, 2021 · 2 shares · 1,192 followers View post →
猫になりたい薬剤師
@Vannyamoto · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 - PubMed 中外製薬の中和抗体を検証した臨床試験 https://t.co/Ci4xOEwxct

Jul 12, 2021 · 2 likes · 2 shares · 1,043 followers View post →
cinefuk
@cinefuk · X

"REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19" #中外製薬 #Regeneron / “カシリビマブ+イムデビマブ” https://t.co/IXT7LajMEi

Jun 29, 2021 · 705 followers View post →
Isatou Sarr
@IsatouSarr4 · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/CQOXIQ8Cty

Jun 21, 2021 · 1 like · 35 followers View post →
Isatou Sarr
@IsatouSarr4 · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/44KG2D69e2

Jun 21, 2021 · 1 like · 35 followers View post →
Anatoly Lubarsky
@anatoly · X

@NashVolGuy @ScottAdamsSays @AndreasShrugged >>There are no other drugs for Covid during the timeframe<< https://t.co/NtgU1VU92Q https://t.co/Ly5z3GOxKX

Jun 17, 2021 · 5,650 followers View post →
Peter K Burian
@PKB_Canada · X

@barronsonline A new concept for treating COVID patients. AstraZeneca is trying it as a preventative, I guess. Their first attempt did not work but others are working on it too. e.g. Regeneron. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@ndtvfeed In simpler terms: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@Reuters_Health In simpler terms: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@TimesNow In simpler terms: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@rapplerdotcom In simpler terms: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@kakape In simpler language: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@livemint This Cocktail is for TREATMENT no prevention. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@japantimes In plain English: A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@TimesLIVE A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@EconomicTimes A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@livemint A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@Reuters_Health A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Regeneron is doing better, apparently. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

A new concept for treating COVID patients. AstraZeneca's first attempt did not work but others are working on it too. Might take a year or two. REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@KamilKaramali OK, Kamil, I want a song about this now REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Peter K Burian
@PKB_Canada · X

@MkingMaria @CTVNews @PHE_uk Here is an article about the research on Antibody Cocktail to treat COVID patients I guess it's not a preventative but a treatment A bit complicated for my non-scientist brain "REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19" https://t.co/2YQNaprueJ

Jun 16, 2021 · 752 followers View post →
Nikkhlesh anand
@nikkhleshanand · X

RT @shams_z: Some important papers on Ab Cocktails. 1. https://t.co/acPVCl3MZw 2. https://t.co/NfAXTia2lJ 3. https://t.co/BDdSskdAZF 4. ht…

May 26, 2021 · 3 shares · 161 followers View post →
Pigeon hate tweet account (STOPFUCKINGFEEDINGTHEM)
@psychedamygdala · X

RT @shams_z: Some important papers on Ab Cocktails. 1. https://t.co/acPVCl3MZw 2. https://t.co/NfAXTia2lJ 3. https://t.co/BDdSskdAZF 4. ht…

May 26, 2021 · 3 shares · 5,543 followers View post →
L Corral-Gudino (tutorCyLlo)
@Luis_Corral_Gud · X

@fgilc @boticariors De momento tendríamos el plasma hiperinmune... quién sabe si la colchicina (COLCORONA trial) y poco más porque remdesivir no tiene indicación hasta más avanzado el caso. Ya era prometedor el análisis intermedio con disminución de la carga viral https://t.co/5mbsXrAxrk

May 22, 2021 · 1 like · 7,337 followers View post →
Dr.医療株
@Dr41013079 · X

@ferbotto @ArgentinoHuman @PabloRichly Considering "REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19" and "SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19", n=650 of PREPARE-IT 2 is fairly significant. Would you consider to announce its interim result?

May 13, 2021 · 2,111 followers View post →
TSK
@TSK010 · X

https://t.co/YLY8SivDuf

May 7, 2021 · 683 followers View post →
Giovanni Landoni, MD
@giovannilandoni · X

@debe the outcomes are those described in trials (human mind is not able to understand if an open label treatment is effective or not; it is only able to introduce biases

Apr 13, 2021 · 4,667 followers View post →
krzysztof
@KrzysztofKanios · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/NtWnJDP7Gu

Feb 3, 2021 · 62 followers View post →
Elias Said, MD, FACEP
@MdFacep · X

In this study, in @NEJM, we examine REGN-COV2: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/9K4kG2EGoa

Feb 2, 2021 · 5,013 followers View post →
COVID Vaccine Tracker
@COVIDVaccineTr2 · X

2 leading pharma companies, Regeneration and Eli Lilly on the race to develop treatment & prophylaxis for COVID patients. Both are neutralizing antibodies or a cocktail of 2. Read up on the results of REGN-CoV2 and LY-CoV555 NEJM: https://t.co/4Rhx1T8oJr https://t.co/YactzdSArT

Jan 26, 2021 · 9 followers View post →
Dr. H. Jürgen Grüner
@gru0680 · X

@ZDFheute Zugehöriger Artikel, steht im Internet: "REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19". Zumindest Erfahrungen mit wissenschaftlichen Artikel im medizinischen Bereich sind m.E. für ein Verständnis dringend erforderlich.

Jan 24, 2021 · 5 followers View post →
Dr. H. Jürgen Grüner
@gru0680 · X

@ZDFheute Originalarbeit: "REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19". Lesenswert. Interessant wäre was Virologen davon halten."Further studies, including the continuing phase 3 portion of this trial, are needed to confirm these effects."

Jan 24, 2021 · 5 followers View post →
Lämêth
@Lam3th · X

@Fischblog Es gibt eine Interimsanalyse. Leicht erkrankte, ambulante Patienten. Reduktion der Viruslast zwar statistisch signifikant aber auch nicht durchschlagend. Gibt's was anderes? https://t.co/AYcC2VWC9Z

Jan 24, 2021 · 1 like · 60,912 followers View post →
Mauricio Montelongo
@eldoctoreme · X

#ARTÍCULO : REGN-COV2, un cóctel de anticuerpos neutralizantes, en pacientes ambulatorios con COVID-19. Descúbrelo en: https://t.co/3IPoEknuV7 O en: https://t.co/gzjRhMwbcm https://t.co/UMA5v98Ygg

Jan 23, 2021 · 2 likes · 13,505 followers View post →
Montani semper liberi
@ecolibertas · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/zyDurMku1e

Jan 22, 2021 · 1 like · 9,236 followers View post →
HAS-veille
@HAS_veille · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/gagrMJKLx1

Jan 21, 2021 · 4,133 followers View post →
Wagner Felix
@astolfi_felix · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/gFEi6si9Ax

Jan 20, 2021 · 1,716 followers View post →
gooochin
@gooochin · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 17, 2021 · 16 shares · 1,654 followers View post →
FMK03
@FMK03 · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 15, 2021 · 16 shares · 1,024 followers View post →
Rodrigo Agüero ⭐⭐⭐
@AgerGastn · X

@CJEllieson @ernestorr Gran hilo Ernesto!. Lo que hay publicado son los resultados del IA de REGN-COV2, no hablan de valor p solo mencionan el IC. Trump recibió tratamiento en Octubre y la FDA recién autorizó el uso (de emergencia) en Noviembre. https://t.co/eP0ht6viB5

Jan 14, 2021 · 1 like · 397 followers View post →
わか❄️(「゚Д゚)「ガウガウ
@wakachuki · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 418 followers View post →
山口 兼一
@cUt55giiq3PrApj · X

RT @kharaguchi: https://t.co/LhSUpBXoJ3 「REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19」 2020/12

Jan 14, 2021 · 1 share · 4,168 followers View post →
ちこママ
@U1yLKzEUPqkDfOa · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 2,366 followers View post →
あき PPPMPPPP
@AM0071 · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 534 followers View post →
yumi @gj
@ygjumi · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 12,718 followers View post →
原口 一博
@kharaguchi · X

https://t.co/LhSUpBXoJ3 「REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19」 2020/12

Jan 14, 2021 · 5 likes · 1 share · 422,919 followers View post →
meltypot
@meltypot · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 1,144 followers View post →
さもありなん:TLほぼ追えてないぽんこつモードなう
@ikotto · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 351 followers View post →
彫木
@CordwainersCat · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 4,283 followers View post →
大泉洋子R
@uni_uni222 · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 1,136 followers View post →
ピョートル4世@
@Pyotr1840 · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 1,491 followers View post →
Tabatha
@araran100 · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 17,562 followers View post →
よりみち(憲法97条消すな!)
@Ernie33Ns · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 829 followers View post →
hannna
@hannahumming · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 2,684 followers View post →
たいしょー。“wanna get higher and further”
@fearless_TAISHO · X

RT @influenzer3: 2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19…

Jan 14, 2021 · 16 shares · 1,358 followers View post →
influenzer
@influenzer3 · X

2種のモノクローナル抗体カクテル製剤のREGN-COV2の報告です。 簡単にまとめておきます。 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 https://t.co/znEhmakdeF

Jan 14, 2021 · 43 likes · 16 shares · 37,857 followers View post →
fujikuro
@fujikurok · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/pqQtXateoz

Jan 14, 2021 · 1,373 followers View post →
BIDMC Infectious Diseases Fellowship
@BIDMC_IDFellows · X

4/ Chen https://t.co/tiNMeqYXDi Weinreich https://t.co/59w4KHb3dx https://t.co/IerFvVJXOh

Jan 7, 2021 · 1 like · 3,563 followers View post →
Dimo Yagcioglu
@DimoYagcioglu · X

@sotostips @YpYgGR @PrimeministerGR https://t.co/X1gUeKY07c REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

Jan 1, 2021 · 4,114 followers View post →
Cure Cancer Now
@CancerCureNow · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19 | NEJM https://t.co/iVPyTgy3eO

Dec 29, 2020 · 6,928 followers View post →
Pablo Guisado Vasco
@PabloGVasco · X

@VirusesImmunity @carolilucas @sneakyvirus1 This research gives lot of sense to the REGN-CoV2 results of dual antibody (Ab) to inhibit #SARSCoV2 Phase 2 trial: benefits in those cases with Ab (-) and higher levels of viral load. Both measures need to select patients @Regeneron @NEJM https://t.co/HJTSg0ToR0

Dec 26, 2020 · 1 like · 1,915 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. https://t.co/IrKJq6pGSA

Dec 23, 2020 · 5,156 followers View post →
Kenar Jhaveri, MD
@kdjhaveri.bsky.social · Bluesky

https://www.nejm.org/doi/full/10.1056/NEJMoa2035002

Dec 18, 2020 View post →
EPIDATUM
@epidatum · X

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with #COVID19 REGN-COV2 antibody cocktail reduced viral load, with a greater effect in patients whose immune response had not yet been initiated or who had a high viral load at baseline. https://t.co/OZGhtsjYU7 https://t.co/81QknjgZNe

Dec 18, 2020 · 1 share · 285 followers View post →
さくら
@Sakura_Med_DSci · X

中和抗体カクテル療法のRCT中間解析結果。NEJM。 ウイルス量は減りそうですね。最終解析が楽しみです。 それにしても、、 海外ではよくこの速度でできますね

Dec 17, 2020 · 7 likes · 17,731 followers View post →
COVID-19 Literature Situation Report
@covid19litrep · X

An interim analysis of the ongoing trial for the antibody cocktail REGN-COV2 among non-hospitalized COVID-19 patients found a larger difference in viral loads among patients in treatment group compared to placebo group. https://t.co/MlcexqUzzH

Dec 17, 2020 · 109 followers View post →
Ady
@AdyAssaf · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 53 followers View post →
PharmaDecisions LLC
@PharmaDecisions · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 454 followers View post →
Ron Cohen, M.D.
@DrRon81 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 2,915 followers View post →
Massato Hirai
@MassatoHirai · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 112 followers View post →
Strong_bio
@strong_bio · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 82 followers View post →
Bryson Duhon, PharmD, BCPS
@Bryson_Duhon · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 293 followers View post →
Safwaan Adam
@safwaan_adam · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 377 followers View post →
Aha?
@Aha_31X3 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 211 followers View post →
Bony fingers
@bonyfingers · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 887 followers View post →
Carlo Favaretti
@carlofavaretti · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 2,316 followers View post →
Alex Salerno
@AlexSalerno10 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 106 followers View post →
α¢нмα∂ нαη∂σкσ | hand
@achmadhandoko · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 279 followers View post →
Klinisk Farmakologisk Afdeling
@KlinFarmBBH · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 91 followers View post →
Mohammed Ali Alshehri د.محمد الشهري
@maab515 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 815 followers View post →
Dr. Preeyam Patel
@thepreesknees · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 596 followers View post →
Meme_Guru2020
@MGuru2020 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 719 followers View post →
Alex Rothbaum
@alexs_pfc · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 112 followers View post →
Petra
@petra28122 · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 616 followers View post →
Jack Hall
@Hall8Jack · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 1,580 followers View post →
Infectious Diseases
@InfectiousDz · X

RT @EricTopol: The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for…

Dec 17, 2020 · 42 shares · 40,890 followers View post →
Eric Topol
@EricTopol · X

The #SARSCoV2 dual antibody(Ab) @Regeneron Phase 2 report for outpatient covid @NEJM today —Most benefit in viral load⬇️ for people w/o native Ab response —Time of symptom onset does not correlate w/ Ab response https://t.co/itwnZp2GzZ https://t.co/JOfiJyQgI4

Dec 17, 2020 · 130 likes · 42 shares · 678,544 followers View post →